These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3126043)
1. Molecular heterogeneity in human beta-galactosidase and neuraminidase deficiency. Galjaard H; Willemsen R; Hoogeveen AT; Mancini GM; Palmeri S; Verheijen FW; D'Azzo A Enzyme; 1987; 38(1-4):132-43. PubMed ID: 3126043 [TBL] [Abstract][Full Text] [Related]
2. Galactosialidosis: molecular heterogeneity among distinct clinical phenotypes. Palmeri S; Hoogeveen AT; Verheijen FW; Galjaard H Am J Hum Genet; 1986 Feb; 38(2):137-48. PubMed ID: 3080874 [TBL] [Abstract][Full Text] [Related]
3. Processing of human beta-galactosidase in GM1-gangliosidosis and Morquio B syndrome. Hoogeveen AT; Graham-Kawashima H; d'Azzo A; Galjaard H J Biol Chem; 1984 Feb; 259(3):1974-7. PubMed ID: 6420416 [TBL] [Abstract][Full Text] [Related]
4. Galactosialidosis: molecular heterogeneity in biosynthesis and processing of protective protein for beta-galactosidase. Nanba E; Tsuji A; Omura K; Suzuki Y Hum Genet; 1988 Dec; 80(4):329-32. PubMed ID: 3143661 [TBL] [Abstract][Full Text] [Related]
5. GM1-gangliosidosis. Defective recognition site on beta-galactosidase precursor. Hoogeveen AT; Reuser AJ; Kroos M; Galjaard H J Biol Chem; 1986 May; 261(13):5702-4. PubMed ID: 3084469 [TBL] [Abstract][Full Text] [Related]
6. Immunoelectron microscopical localization of lysosomal beta-galactosidase and its precursor forms in normal and mutant human fibroblasts. Willemsen R; Hoogeveen AT; Sips HJ; van Dongen JM; Galjaard H Eur J Cell Biol; 1986 Mar; 40(1):9-15. PubMed ID: 3084261 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts. D'Agrosa RM; Hubbes M; Zhang S; Shankaran R; Callahan JW Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):833-8. PubMed ID: 1497621 [TBL] [Abstract][Full Text] [Related]
8. Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency. Mancini GM; Hoogeveen AT; Galjaard H; Mansson JE; Svennerholm L Hum Genet; 1986 May; 73(1):35-8. PubMed ID: 3086209 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. Callahan JW Biochim Biophys Acta; 1999 Oct; 1455(2-3):85-103. PubMed ID: 10571006 [TBL] [Abstract][Full Text] [Related]
10. GM1-gangliosidosis: abnormalities in biosynthesis and early processing of beta-galactosidase in fibroblasts. Nanba E; Tsuji A; Omura K; Suzuki Y Biochem Biophys Res Commun; 1988 Apr; 152(2):794-800. PubMed ID: 3130055 [TBL] [Abstract][Full Text] [Related]
11. Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders. Mueller OT; Henry WM; Haley LL; Byers MG; Eddy RL; Shows TB Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1817-21. PubMed ID: 3081902 [TBL] [Abstract][Full Text] [Related]
12. [Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis]. Vel'tishchev IuE; Kalaidzhieva LV Vopr Med Khim; 1979; 25(6):709-15. PubMed ID: 117628 [TBL] [Abstract][Full Text] [Related]
13. Galactosialidosis: a direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts. Nanba E; Tsuji A; Omura K; Suzuki Y Biochem Biophys Res Commun; 1987 Apr; 144(1):138-42. PubMed ID: 3107551 [TBL] [Abstract][Full Text] [Related]
14. Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency. van Diggelen OP; Hoogeveen AT; Smith PJ; Reuser AJ; Galjaard H Biochim Biophys Acta; 1982 Apr; 703(1):69-76. PubMed ID: 6803839 [No Abstract] [Full Text] [Related]
15. The relation between human lysosomal beta-galactosidase and its protective protein. Hoogeveen AT; Verheijen FW; Galjaard H J Biol Chem; 1983 Oct; 258(20):12143-6. PubMed ID: 6415049 [TBL] [Abstract][Full Text] [Related]
16. Interspecific genetic complementation analysis of human and sheep fibroblasts with beta-galactosidase deficiency. Ahern-Rindell AJ; Murnane RD; Prieur DJ Somat Cell Mol Genet; 1989 Nov; 15(6):525-33. PubMed ID: 2512653 [TBL] [Abstract][Full Text] [Related]
17. Elastogenesis in cultured dermal fibroblasts from patients with lysosomal beta-galactosidase, protective protein/cathepsin A and neuraminidase-1 deficiencies. Tatano Y; Takeuchi N; Kuwahara J; Sakuraba H; Takahashi T; Takada G; Itoh K J Med Invest; 2006 Feb; 53(1-2):103-12. PubMed ID: 16538002 [TBL] [Abstract][Full Text] [Related]
18. The presence of a reduced amount of 32-kd "protective" protein is a distinct biochemical finding in late infantile galactosialidosis. Strisciuglio P; Parenti G; Giudice C; Lijoi S; Hoogeveen AT; d'Azzo A Hum Genet; 1988 Nov; 80(3):304-6. PubMed ID: 3142815 [TBL] [Abstract][Full Text] [Related]
19. Cathepsin A/protective protein: an unusual lysosomal multifunctional protein. Hiraiwa M Cell Mol Life Sci; 1999 Dec; 56(11-12):894-907. PubMed ID: 11212324 [TBL] [Abstract][Full Text] [Related]
20. Morquio B syndrome: a primary defect in beta-galactosidase. van der Horst GT; Kleijer WJ; Hoogeveen AT; Huijmans JG; Blom W; van Diggelen OP Am J Med Genet; 1983 Oct; 16(2):261-75. PubMed ID: 6418007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]